AMRYT PHARMA PLC - SPNR ADR (AMYT) Stock Analyst Ratings
USA - NASDAQ:AMYT - US03217L1061 - ADR
14.7 USD
+0.01 (+0.07%)
14.7 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to AMYT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.48. This target is 148.2% above the current price.
AMYT was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AMYT.
In the previous month the buy percentage consensus was at a similar level.
AMYT was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-01-10 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-01-10 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-01-10 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-01-09 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-06-24 | SVB Leerink | Maintains | Outperform |
| 2022-05-05 | SVB Leerink | Maintains | Outperform |
| 2022-03-10 | SVB Leerink | Maintains | Outperform |
| 2022-03-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-23 | SVB Leerink | Maintains | Outperform |
| 2021-10-04 | JonesTrading | Initiate | Buy |
| 2021-08-19 | SVB Leerink | Initiate | Outperform |
| 2021-07-27 | HC Wainwright & Co. | Initiate | Buy |
| 2021-03-31 | Maxim Group | Initiate | Buy |
AMRYT PHARMA PLC - SPNR ADR / AMYT FAQ
What is the price target for AMYT stock?
7 analysts have analysed AMYT and the average price target is 36.48 USD. This implies a price increase of 148.2% is expected in the next year compared to the current price of 14.7.
What is the consensus rating for AMYT stock?
The consensus rating for AMRYT PHARMA PLC - SPNR ADR (AMYT) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.